Document is current
Any future updates will be listed below
-
Authors
Chen, Jianhao
Pang, Yizhen
Liao, Xiyi
Zhou, Yangfan
Luo, Qicong
Wu, Hua
Zuo, Changjing
Zhang, Jingjing
Lin, Qin
Chen, Xiaoyuan
Zhao, Liang
Chen, Haojun https://orcid.org/0000-0002-9101-8884
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82071961)
Key Scientific Research Program for Yong Scholars in Fujian (2021ZQNZD016)
Fujian Natural Science Foundation for Distinguished Yong Scholars (2022D005)
National Medical Research Council (MOH-001388-00, CG21APR1005)
Singapore Ministry of Education (MOE-000387-00)
National Research Foundation (NRF-000352-00)
the National University of Singapore (NUHSRO/2020/133/Startup/08, NUHSRO/2023/008/NUSMed/TCE/LOA, NUHSRO/2021/034/TRP/09/Nanomedicine)
- License Information
-
More Information
Article History
Received: 6 May 2024
Accepted: 4 August 2024
First Online: 15 August 2024
Declarations
:
: All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any experiments with animals.
: Informed consent was obtained from all individual participants included in the study.
: X Chen is co-founder of the Yantai LNC Biotechnology. The other authors declare that they have no potential conflicts of interest.
